Trials / Completed
CompletedNCT02806908
Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Narcolepsy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Jazz Pharmaceuticals · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of JZP-110 on driving performance in subjects with excessive sleepiness due to narcolepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JZP-110 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-05-19
- Completion
- 2019-05-19
- First posted
- 2016-06-21
- Last updated
- 2021-01-13
- Results posted
- 2021-01-13
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02806908. Inclusion in this directory is not an endorsement.